# Cephea Early Feasibility Study

> **NCT05061004** · NA · RECRUITING · sponsor: **Abbott Medical Devices** · enrollment: 50 (estimated)

## Conditions studied

- Mitral Regurgitation

## Interventions

- **DEVICE:** Cephea Mitral Valve System

## Key facts

- **NCT ID:** NCT05061004
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-28
- **Primary completion:** 2026-12-31
- **Final completion:** 2031-03-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05061004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05061004, "Cephea Early Feasibility Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05061004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*